Correlation Between the Japanese Version of the High Bleeding Risk (J-HBR) Criteria and the PRECISE-DAPT Score, and Optimal J-HBR Cut-Off Score to Predict Major Bleeding

Figures

• 

  Figure 1.. Prevalence of each criterion included in the Japanese version of high bleeding risk (J-HBR). BW, body weight; CKD, chronic kidney disease; NSAIDs, non-steroidal anti-inflammatory drugs; PVD, peripheral vascular disease.

• 

  Figure 2.. Correlation analysis between the Japanese version of high bleeding risk (J-HBR) criteria and the PRECISE-DAPT score.

• 

  Figure 3.. Kaplan-Meier curves of (A) major bleeding and (B) ischemic events (myocardial infarction [MI] and ischemic stroke) according to high bleeding risk (HBR) status based on the Japanese version of high bleeding risk (J-HBR) criteria and the PRECISE-DAPT score. The presence of HBR (HBR(+)), was defined as a J-HBR score ≥1.0 and a PRECISE-DAPT score ≥25. PCI, percutaneous coronary intervention.

• 

  Figure 4.. Receiver operating characteristic curves for the incidence of major bleeding and ischemic events (myocardial infarction [MI] and ischemic stroke) according to high bleeding risk (HBR) status based on the Japanese version of high bleeding risk criteria (J-HBR) and PRECISE-DAPT score. The optimal cut-off value on the J-HBR for predicting major bleeding events based on Youden’s Index was 1.5. AUC, area under the curve.

• 

  Figure 5.. Kaplan-Meier curves of major bleeding and ischemic events (myocardial infarction [MI] and ischemic stroke) according the modified Japanese version of high bleeding risk criteria (J-HBR), in which a score ≥1.5 is taken to indicate high bleeding risk. PCI, percutaneous coronary intervention.